Iq Eq Fund Management (Ireland) LTD Intellia Therapeutics, Inc. Transaction History
Iq Eq Fund Management (Ireland) LTD
- $831 Million
- Q4 2024
A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 54,657 shares of NTLA stock, worth $512,136. This represents 0.08% of its overall portfolio holdings.
Number of Shares
54,657
Previous 23,031
137.32%
Holding current value
$512,136
Previous $473,000
34.67%
% of portfolio
0.08%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding NTLA
# of Institutions
336Shares Held
96.1MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$117 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$95.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$89.9 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$48.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$35.7 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $712M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...